Economic Observation Network Aonong Biotechnology (603363) released its 2026 semi annual report, showing a year-on-year increase in revenue but a loss in net profit attributable to the parent company. There are also issues such as filing for violations of disclosure regulations.

Performance and business situation:
In the first half of the year, the revenue reached 4.521 billion yuan, a year-on-year increase of 14.25% From a business perspective, the feed business holds up the majority of the market (revenue of 3.143 billion yuan, accounting for 69.52%), while aquaculture and slaughter food account for 16.89% and 13.34% respectively. This income structure determines that the company is essentially more like a 'feed seller', and the direct impact of pig prices on profits is lower than that of pure breeding enterprises. The net profit attributable to the parent company was a loss of 190 million yuan, which turned from profit to loss year-on-year (with a profit of 361 million yuan in the same period last year) The main reason for the loss is the low sales price of live pigs combined with an increase in the number of slaughtered pigs, leading to the expansion of losses in the pig farming business - note that this is a typical headwind situation of "increasing quantity but decreasing price". What is even more alarming is that the net outflow of cash flow from operating activities was 329 million yuan, continuing the bleeding state of the same period last year Deducting non recurring net profit resulted in a greater loss (-252 million yuan), indicating that the main business's ability to generate revenue is still worrying One reason is that the main profit of the same period last year was about 380 million yuan in restructuring income. This year, this "unexpected windfall" has disappeared, so the base effect on the profit side is very significant 。

Violation disclosure situation:
The company is currently under investigation by the China Securities Regulatory Commission for violating its disclosure regulations.

Financial situation:
The book value of accounts receivable has increased to 721 million yuan, accounting for over 20% of current assets, and the recovery risk cannot be ignored The asset liability ratio is 62.08%, ranking in the middle of the industry 。

Overall, this interim report is a combination of "revenue expansion and quality decline".

The above content is based on publicly available information and does not constitute investment advice.